Biogen (BIIB) Treasury Shares (2016 - 2025)
Historic Treasury Shares for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $3.0 billion.
- Biogen's Treasury Shares changed 0.0% to $3.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.0 billion for FY2025, which is 0.0% changed from last year.
- Biogen's Treasury Shares amounted to $23.8 million in Q4 2025, which was down 0.0% from -$23.8 million recorded in Q1 2025.
- Biogen's Treasury Shares' 5-year high stood at $23.8 million during Q4 2021, with a 5-year trough of -$23.8 million in Q1 2022.
- Over the past 5 years, Biogen's median Treasury Shares value was $2.4 million (recorded in 2022), while the average stood at -$1.7 million.
- The largest annual percentage gain for Biogen's Treasury Shares in the last 5 years was 0.0% (2021), contrasted with its biggest fall of 0.0% (2021).
- Biogen's Treasury Shares (Quarter) stood at $3.0 billion in 2021, then changed by 0.0% to $3.0 billion in 2022, then changed by 0.0% to $3.0 billion in 2023, then changed by 0.0% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025.
- Its Treasury Shares was $3.0 billion in Q4 2025, compared to $3.0 billion in Q3 2025 and $3.0 billion in Q2 2025.